These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5582479)

  • 41. Identification of serum cholinesterase fluoride variants by differential inhibition in tris and phosphate buffers.
    Garry PJ; Owen GM; Lubin AH
    Clin Chem; 1972 Feb; 18(2):105-9. PubMed ID: 5008517
    [No Abstract]   [Full Text] [Related]  

  • 42. [Occurrence of progressive muscular dystrophy in Denmark].
    Leth A; Bang N
    Ugeskr Laeger; 1974 Jul; 136(31):1731-6. PubMed ID: 4410255
    [No Abstract]   [Full Text] [Related]  

  • 43. [Changes of the lipid content of skeletal muscles in progressive muscular dystrophy as a basis for a hypothesis of a primary enzyme defect].
    Kunze D; Olthoff D; Schellnack K
    Acta Biol Med Ger; 1968; 21(5):669-78. PubMed ID: 5739848
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the current treatment of progressive muscular dystrophies in children].
    Edel'shteĭn EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):173-7. PubMed ID: 4385315
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinico-statistical considerations on a group of 22 patients with progressive muscular dystrophy].
    Garofalo E; Marcer V
    Fracastoro; 1966; 59(6):621-38. PubMed ID: 5998705
    [No Abstract]   [Full Text] [Related]  

  • 46. [Problems of genetically determined serum cholinesterase types].
    Thomas K; Hofmann F; Stritzke R
    Dtsch Gesundheitsw; 1970 Sep; 25(38):1785-8. PubMed ID: 5485250
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the enzymatic differential diagnosis of the involvement of various organs in Erb's progressive muscular dystrophy during three medications].
    Kleine TO; Chlond H
    Enzymol Biol Clin (Basel); 1969; 10(1):39-67. PubMed ID: 5305371
    [No Abstract]   [Full Text] [Related]  

  • 48. The inheritance of progressive muscular dystrophy in Japan.
    Murakami U
    Jinrui Idengaku Zasshi; 1967 Dec; 12(3):150-69. PubMed ID: 5626875
    [No Abstract]   [Full Text] [Related]  

  • 49. A family of progressive muscular dystrophy with mental retardation. Clinical observations.
    Suga M; Yoshimuta S; Hayashi Y; Sakamoto F
    Jinrui Idengaku Zasshi; 1966 Mar; 10(4):189-92. PubMed ID: 6008646
    [No Abstract]   [Full Text] [Related]  

  • 50. A preliminary study of serum beta-glucuronidase enzyme activity in progressive muscular dystrophies.
    Vainzof M; Zatz M
    Am J Med Genet; 1985 Jun; 21(2):395-9. PubMed ID: 4014319
    [No Abstract]   [Full Text] [Related]  

  • 51. Sernylan inhibition of human serum cholinesterase.
    Becker CE
    Hum Hered; 1972; 22(1):55-7. PubMed ID: 5036636
    [No Abstract]   [Full Text] [Related]  

  • 52. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 53. [Features of the course and treatment of progressive muscular dystrophy associated with chronic suppurative diseases].
    Abdukhakimov FT; Islamov IB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):362-7. PubMed ID: 7395411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic possibilities in myopathies, specifically in progressive muscular dystrophy].
    Beckmann R
    Arch Kinderheilkd; 1965 Nov; 173(2):109-34. PubMed ID: 5329080
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Amino acid plotting charts in progressive muscular dystrophy. Family studies].
    Beckmann R; Ritter H
    Dtsch Med Wochenschr; 1966 Dec; 91(52):2231-5. PubMed ID: 5926730
    [No Abstract]   [Full Text] [Related]  

  • 57. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
    Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
    [No Abstract]   [Full Text] [Related]  

  • 58. [The electrocardiogram in progressive muscular dystrophy and myotonic diseases. A study of 77 patients].
    Galvão PB; Werneck LC; Germiniani H; da Cunha GP
    Arq Bras Cardiol; 1984 Apr; 42(4):273-9. PubMed ID: 6508582
    [No Abstract]   [Full Text] [Related]  

  • 59. Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease.
    Jackson CE; Strehler DA
    Pediatrics; 1968 Feb; 41(2):495-502. PubMed ID: 5637795
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical significance of pseudocholinesterase activity in children with burns].
    Gudumak EM
    Vestn Khir Im I I Grek; 1972 May; 108(5):75-7. PubMed ID: 5035020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.